Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 17, 2025 • 12:00 AM ET

Date/Time Source News Release
06/10/2025 08:00 AM EDT PR Newswire Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S
05/27/2025 09:00 AM EDT PR Newswire Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
05/16/2025 05:30 PM EDT PR Newswire Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
05/07/2025 04:01 PM EDT PR Newswire Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results
05/05/2025 08:00 AM EDT PR Newswire Vanda Announces Bysanti(TM) NDA Filing; FDA Decision Expected in Early 2026
05/02/2025 08:46 AM EDT PR Newswire Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025
04/23/2025 03:52 PM EDT PR Newswire FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA
04/07/2025 08:00 AM EDT PR Newswire Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting
03/31/2025 08:00 AM EDT PR Newswire Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti(TM) for the Treatments of Acute Bipolar I Disorder and Schizophrenia
02/24/2025 07:00 AM EST PR Newswire Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"
Page

Additional News

As of June 17, 2025 • 12:00 AM ET

Date/Time Source News Release
06/16/2025 11:30 AM EDT SeekingAlpha Tonix Pharmaceuticals: Big Risk, Bigger Reward - Initiating With A Buy
05/07/2025 07:56 PM EDT SeekingAlpha Vanda pharmaceuticals outlines $210M-$250M revenue target for 2025 amid product launches
05/07/2025 07:55 PM EDT SeekingAlpha Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript
05/07/2025 05:10 PM EDT Zacks Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates
05/07/2025 04:04 PM EDT SeekingAlpha Vanda Pharmaceuticals GAAP EPS of -$0.50 beats by $0.10, revenue of $50.04M beats by $4.91M
05/07/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, May 7th, 2025
05/07/2025 05:31 AM EDT US Earnings Reports Expected earnings - Vanda Pharmaceuticals Inc.
05/01/2025 05:35 PM EDT Zacks Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
04/23/2025 04:58 PM EDT SeekingAlpha Vanda claims FDA 'unlawfully' delays hearing request on tradipitant decision
04/07/2025 02:21 PM EDT SeekingAlpha Vanda Pharmaceuticals: Financials Are Great, But Market Reaction Is Confusing
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.